carbamazepine
Boxed Warning
Serious dermatologic reactions (Stevens-Johnson syndrome / TEN) — especially in HLA-B*1502 positive individuals. Aplastic anemia and agranulocytosis.
Carbamazepine is an anticonvulsant used for bipolar (especially mania), epilepsy, and trigeminal neuralgia. Notable for autoinduction of its own metabolism and a black-box warning for serious skin reactions in HLA-B*1502-positive individuals.
100mg, 200mg tablets; 100mg/5mL suspension; 100mg, 200mg, 400mg ER
Tablets: 200mg; Chewable tablets: 100mg; Suspension: 100mg/5mL; ER tablets: 100mg, 200mg, 400mg; ER capsules: 100mg, 200mg, 300mg
Category D
Voltage-gated sodium channel blocker; decreases neuronal excitability.
Slow taper over weeks. Watch for return of induced enzyme drug interactions as carbamazepine clears.
Carbamazepine's enzyme induction means many concurrent drugs will need dose review during the taper as their metabolism slows.
3-7 days after stopping
1-2 weeks
4-8 weeks
Mood instability can persist months without alternative coverage
Toxicity
Stevens-Johnson syndrome / TEN (especially HLA-B*1502 in Asian populations), aplastic anemia, agranulocytosis, hyponatremia (SIADH), hepatotoxicity, dizziness, ataxia, diplopia.
Pharmacokinetics
Hepatic via CYP3A4 (major). Potent inducer of CYP3A4, CYP1A2, CYP2C9, UGT — induces own metabolism over the first weeks.
~76%
Browse our map of deprescribing-informed providers worldwide.